Options traders are pricing in the most defensive posture seen on BNY in weeks. The put-call ratio hit 1.45 on August 19 — a 3.88 sigma deviation above its 20-day mean. That's an extreme reading, and it arrived as short sellers were already adding exposure.
The PCR of 1.45 is the highest since July 27. The 20-day mean sits at 1.31, with a standard deviation of just 0.036. Getting to 3.88 sigma above that mean requires a sharp and sudden shift in how options participants are positioning. Puts now heavily outnumber calls relative to recent norms. Next earnings is due October 15.
Short interest has risen 11.6% over the past week to 1.19% of free float. That is a notable pace of change. The absolute level, however, remains low — well below anything that creates structural short-side pressure on a stock of BNY's size. The borrow market confirms this. Availability stands at 9,999% of current short interest — shares to borrow are essentially unlimited. Cost to borrow rose 58% over the same week, but from a very low base, now sitting at just 0.47%. There is no squeeze risk here.
The bearish options tone sits at odds with a constructive analyst backdrop. JP Morgan raised its price target to $159 on August 4, maintaining Overweight. Argus Research lifted its target to $180 in late July. Bank of America, Barclays, and Keefe Bruyette & Woods all raised targets following Q2 results in mid-July. The consensus mean target is $167.33, roughly 4.7% above the August 19 close of $159.76.
BNY's most comparable peers — STT and NTRS — were both down more than 2.5% on the day, suggesting sector-wide pressure rather than a BNY-specific story.
See the live data behind this article on ORTEX.
Open BNY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
